HHealthcare Read More FDA Pulls Warning Labels From Hormone Replacement TherapiesNovember 11, 2025 Hormone replacement therapies used to treat menopause symptoms no longer need to carry strict warnings about some potential…
BBusiness Read More Pfizer Sweetens Its Offer for Metsera in Bidding War Against NovoNovember 8, 2025 Pfizer Inc. agreed to buy Metsera Inc. for up to $10 billion, prevailing over Novo Nordisk A/S in…
MMedication Read More Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in StudyNovember 6, 2025 Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
HHealthcare Read More Metsera calls Novo Nordisk’s new bid superior to Pfizer offerNovember 4, 2025 The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
BBusiness Read More What’s likely to move the market in the next trading sessionNovember 4, 2025 Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
HHealthcare Read More Pfizer files second lawsuit against Novo Nordisk, MetseraNovember 3, 2025 A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
HHealthcare Read More Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidOctober 31, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
HHealthcare Read More Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid – Bloomberg.comOctober 31, 2025 Pfizer Races to Salvage Obesity Drugmaker Deal After Novo’s Bid Bloomberg.comNovo Nordisk’s Metsera bid shows how far it’ll go…
HHealthcare Read More Why an Old Multiple Sclerosis Drug Costs More Than Ever in the USOctober 29, 2025 When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year.…
MMedication Read More Eli Lilly Novo Nordisk stock fall on Trump GLP-1 price commentsOctober 24, 2025 Shares of Eli Lilly and Novo Nordisk dropped Friday, after President Donald Trump said his administration aims to…
HHealthcare Read More Pfizer’s Q3 2025 Earnings: What to ExpectOctober 19, 2025 With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known…
HHealthcare Read More Trump announces efforts to expand access to IVF drugsOctober 16, 2025 U.S. President Donald Trump delivers remarks before signing an executive order on expanding access to IVF at his…